AbbVie Inc. — Director's Dealing 2022

Feb 8, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2022-02-07

Reporting Person: Strom Carrie C (SVP & Pres Global Allerg Aesth)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-07	Common Stock, $0.01 par value	A	4184	$47.27	Acquired	44895	Direct
2022-02-07	Common Stock, $0.01 par value	S	2396	$141.17	Disposed	42499	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-07	Option (right to buy)	$47.27	M	4184	Acquired	2022-02-17	Common Stock (4184)	Direct

Footnotes

F1: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.